Beryllium Summit 2011:
4th International Conference on Beryllium Disease
October 20-22, 2011
InterContinental Hotel and Bank of America Conference Center
Cleveland, Ohio
Description
The conference will cover recent innovations in the prevention, evaluation, and management of chronic beryllium disease including primary, secondary, and tertiary preventive strategies for this exposure-related disease.
This conference will also provide a review and analysis of current research, new treatment strategies, and clinical practice management options with the goal of increasing practitioners’ knowledge and competencies and, thus, reducing the incidence and complications of beryllium disease.
Key topics
- Human health effects of beryllium
- Beryllium exposure
- Immunology and pathogenic mechanisms
- Genetics, genomics, and gene environmental interactions
- Future directions
Target Audience
Designed for pulmonologists, occupational medicine practitioners, medical directors and health and safety managers of beryllium-using facilities, industrial hygienists, government workers and regulators, and health care professionals involved in the diagnosis and clinical management of patients with beryllium sensitization and chronic beryllium disease.
Objectives
- Perform a differential diagnosis of chronic beryllium disease in patients with a history of environmental exposure to beryllium;
- Compare and contrast recent advances in diagnostic tests for chronic beryllium disease;
- Describe current research findings in the genomics associated with beryllium sensitization;
- Summarize pathogenesis of immunology and pathogenic mechanisms associated with development of chronic beryllium disease;
- Describe exposure pathways and biological relevance;
- Define the role of beryllium sensitization in chronic beryllium disease.
Call for AbstractsThe organizing committee for the Beryllium Summit 2011: 4th International Conference on Beryllium Disease is currently accepting abstracts / posters. Click Here To Submit Your AbstractSuggested Topic Categories – (not limited to these suggestions)
Opening and Deadline Review Process Acceptance and Registration General Abstract Information Abstracts/posters must be free of commercial bias. In addition, they may not imply an endorsement of any service by their institution or the Cleveland Clinic. Authors should pay close attention to formatting instructions. All research papers submitted must be formatted according to guidelines. Abstract/Poster Submission Official Language Author Affiliation Text of the Abstract/Poster
B. The use of standard abbreviations is acceptable. Other abbreviations should be placed in parentheses, after the first appearance of the full word(s) for which it stands. C. Topic: Abstracts/posters must relate to Beryllium. For Additional Abstract Information Click Here To Submit Your Abstract |
Director
Raed A. Dweik, MD |
Planning Committee
Lisa Barker, BS Chantal Dion, PhD Lisa A. Maier, MD, MSPH |
Lee S. Newman, MD, MA Milton D. Rossman, MD |
Faculty
Michael J. Brisson Donna L. Cragle, PhD Daniel A. Culver, DO, FCCP Kristin J. Cummings, MD, MPH Brian J. Day, PhD Amanda Edens Carol F. Farver, MD Elizabeth Fireman, PhD Andrew P. Fontenot, MD Mark D. Hoover, PhD, CHP, CIH Thomas M. McCleskey, PhD Dannie C. Middleton, MD, MPH |
Peggy M. Mroz, MSPH Joachim Müller-Quernheim, MD, PhD Gaston Ostiguy Cesare Saltini, PhD Janet Shorter, RN Lori J. Silveira, PhD Carmen M. Swaisgood, PhD James S. Taylor, MD Mike Van Dyke, PhD, CIH M. Abbas Virji, ScD, MSc, CIH Herbert P. Wiedemann, MD, MBA Belinda Yen-Lieberman, PhD |
Agenda
Thursday, Oct. 20 | Friday, Oct.21 | Saturday, Oct.22
| THURSDAY, OCTOBER 20, 2011 | |
| 7:00 am | Registration / Continental Breakfast |
| 8:00 am | Welcome - Herbert Wiedemann, MD |
| 8:10 am | Overview and Goals of the Meeting - Raed Dweik, MD |
| Human Health Effects of Beryllium | |
| 8:15 am | Clinical Overview and Advances in Beryllium Sensitization and Chronic Beryllium Disease Diagnosis and Management - Raed Dweik, MD |
| 8:45 am | Disease Severity and Treatment - Milton Rossman, MD |
| 9:15 am | Lung Pathology in Chronic Beryllium Disease - Carol Farver, MD |
| 9:45 am | Refreshment Break |
| 10:00 am | Optimizing BeLPT Criteria for Beryllium Sensitization - Dan Middleton, MD |
| 10:30 am | Beryllium Lymphocyte Proliferation Test (BeLPT) Primer - Belinda Yen-Lieberman, PhD |
| 11:00 am | National Supplemental Screening Program - Donna Cragle, PhD |
| 11:30 am | New Tests for Detecting Beryllium Sensitization - Andrew Fontenot, MD |
| 12:00 pm | Overview of Recent Epidemiologic Studies - Peggy Mroz, MSPH |
| 12:30 pm | Lunch |
| 1:30 pm | Energy Employees Occupational Illness Compensation Program - Rachel Leiton |
| 2:00 pm | Treatment of CBD: Lessons Learned from Sarcoidosis - Dan Culver, DO |
| Beryllium Exposure | |
| 2:30 pm | Exposure Pathways - M. Abbas Virji, ScD |
| 3:00 pm | Beryllium and the Skin: A Dermatologic Perspective - James Taylor, MD |
| 3:30 pm | Refreshment Break |
| 3:45 pm | Biologically Relevant Exposures to Beryllium - M. Abbas Virji, ScD |
| 4:15 pm | Beryllium BioRepository and Opportunities for Research - Lee Newman, MD |
| 5:00 pm | Abstract Presentations |
| Back to Top | |
| FRIDAY, OCTOBER 21, 2011 | |
| 7:30 am | Registration / Continental Breakfast |
| Immunology and Pathogenic Mechanisms | |
| 8:00 am | Development of a Sarcoidosis Murine Lung Granuloma Model Using Mycobacterium Superoxide Dismutase A - Carmen Swaisgood, PhD |
| 8:45 am | The Role of Oxidative Stress in Chronic Beryllium Disease - Brian Day, PhD |
| 9:15 am | Abstract Presentations |
| 10:30 am | Refreshment Break |
| 11:00 am | Beryllium Disease and Sensitization: The Quebec Experience 1990-2011- Gaston Ostiguy, MD |
| 11:45 am | Using Administrative Databases to Find Beryllium Disease Risk in British Columbia - Tim Takaro, MD |
| 12:30 pm | Lunch |
| Exposure Characteristics, Internal Dosimetry | |
| 1:30 pm | Reassessing the Current Exposure Limits - Amanda Edens |
| 2:00 pm | Physicochemical Characterization of Beryllium - Mark Hoover, PhD |
| 2:30 pm | Beryllium Binding and Chemistry - T. Mark McCleskey, PhD |
| 3:00 pm | Lung Deposition Model - Mark Hoover, PhD |
| 3:30 pm | Refreshment Break |
| 3:45 pm | Induced Sputum Analyses in Beryllium-Exposed Dental Technicians - Elizabeth Fireman, PhD |
| 4:15 pm | Beryllium Health and Safety Committee Activities and Research Needs - Mike Brisson |
| Back to Top | |
| SATURDAY, OCTOBER 22, 2011 | |
| 7:30 am | Registration / Continental Breakfast |
| Genetics, Genomics, and Gene-Environment Interactions | |
| 8:00 am | Genome-Wide Search for the Detection of Genes Associated with Immune Mediated Diseases - Dimitri Monos, PhD |
| 8:30 am | Predictive Value of HLA-DPB1 Alleles- Ainsley Weston, PhD |
| 9:00 am | The Genetics of Be-MHC Binding - Cesare Saltini, PhD |
| 9:30 am | Contribution of Exposure and Genetics to the Development of Beryllium Sensitization and Chronic Beryllium Disease - Mike Van Dyke, PhD |
| 10:00 am | Refreshment Break |
| 10:15 am | The Genetics of Severe Lung Disease - Lori Silveira, PhD |
| 10:45 am | Preventing Sensitization and Disease from Beryllium Exposure - Christine Schuler, PhD |
| Updates: Future Directions | |
| 11:15 am | What Beryllium Can Teach the Indium Industry - Kristin Cummings, MD |
| 11:45 am | Development of German Evidence-Based Occupational Health Guidelines for Chronic Beryllium Disease - Joachim Müller-Quernheim, MD, PhD |
| 12:15 pm | American Thoracic Society Consensus Statement Update - Lisa Maier, MD |
| 12:45 pm | Lunch |
| Patient Perspective | |
| 1:45 pm | Patient and Worker Oriented Session Moderator: Raed Dweik, MD Panel: Lisa Barker, BS |
| Closing Session | |
| 3:15 pm | Symposium Summary - Lisa Maier, MD |
| 3:30 pm | Closing Remarks - Raed Dweik, MD |
| 3:45 pm | Adjourn |
Location
InterContinental Hotel and
Bank of America Conference Center
9801 Carnegie Avenue
Cleveland, OH 44106
Phone: 216.707.4100 or 877.707.8999
|
View Larger Map |
Hotel Accommodations
A block of rooms has been reserved at the InterContinental Hotel until 5:00 PM ET, September 19, 2011. To make your reservations, contact the Hotel Reservations Department at 216.707.4000 or 1.877.707.8999. Please identify yourself as being with the Cleveland Clinic Beryllium Summit 2011: 4th Annual International Conference on Beryllium Disease.
Special rates are listed below:
- InterContinental Conference Hotel, $189 single/double plus tax (online code REL)
- InterContinental Suite Hotel, $169 single/double plus tax (online code D06)
The InterContinental Conference Hotel is located at 9801 Carnegie Avenue, on the campus of the Cleveland Clinic. The Suite Hotel is located at 8800 Euclid Avenue and is within walking distance to the InterContinental Hotel and Bank of America Conference Center.
Ground Transportation
Taxi service is available from Cleveland Hopkins International Airport to the InterContinental Hotel and Bank of America Conference Center.
Parking
Parking is available in the East 100th St. Carnegie Avenue Visitor's Parking Garage at prevailing rates. Valet parking is available at the hotel for an additional charge.
Additional Information
For further information about the course, contact Cleveland Clinic Center for Continuing Education at:
Local: 216.448.0770
Toll Free: 800.238.6750
For questions about registering online, call 216.448.0777 or email CMEregistration@ccf.org.
Faculty Disclosure
The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.
Americans with Disabilities Act
The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify us at least two weeks prior to the activity.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Cleveland Clinic (OH-045/10-1-12) is an approved provider of continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Online Registration/Fees
| Category | Full Event | Per Day |
|---|---|---|
| Physician | $750.00 | $285.00 |
| Corporate | $750.00 | $285.00 |
| CCF Comprecare | $487.50 | $205.00 |
| CCF Alumni | $450.00 | $185.00 |
| Resident / Fellow | $450.00 | $185.00 |
| Nurse Practitioner / Nurse / Allied Health Professional / Physician Assistant / Other | $450.00 | $185.00 |
| CCHS Physician | $750.00 | $285.00 |
| CCHS Fellow / Resident | $225.00 | $115.00 |
| CCHS Nurse Practitioner / Nurse / Allied Health Professional / Physician Assistant / Other | $225.00 | $115.00 |
| CCF Physician | $375.00 | $165.00 |
| CCF Resident / Fellow | $225.00 | $115.00 |
| CCF Nurse Practitioner / Nurse / Allied Health Professional / Physician Assistant / Other | $225.00 | $115.00 |
Please call 216.448.0777 for per day registration
Cancellation Policy
Preregistrations are accepted by fax or online until 4:00 pm ET October 18, 2011. Please register onsite after this date. In case of cancellation, a full refund will be made if canceled by Tuesday, October 11, 2011. After October 11, 2011, a $100 cancellation fee will be deducted from your refund. Written notification of your cancellation is required to process your refund.NO REFUNDS WILL BE ISSUED AFTER November 30, 2011.
For questions about registration, please call 216.448.0777 or email us at cmeregistration@ccf.org.
